Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 139

1.

Establishment and characterization of a lethal mouse model for the Angola strain of Marburg virus.

Qiu X, Wong G, Audet J, Cutts T, Niu Y, Booth S, Kobinger GP.

J Virol. 2014 Nov;88(21):12703-14. doi: 10.1128/JVI.01643-14.

2.

Development and characterization of a mouse model for Marburg hemorrhagic fever.

Warfield KL, Bradfute SB, Wells J, Lofts L, Cooper MT, Alves DA, Reed DK, VanTongeren SA, Mech CA, Bavari S.

J Virol. 2009 Jul;83(13):6404-15. doi: 10.1128/JVI.00126-09.

3.

Development of a model for marburgvirus based on severe-combined immunodeficiency mice.

Warfield KL, Alves DA, Bradfute SB, Reed DK, VanTongeren S, Kalina WV, Olinger GG, Bavari S.

Virol J. 2007 Oct 25;4:108.

4.

Comparison of the Pathogenesis of the Angola and Ravn Strains of Marburg Virus in the Outbred Guinea Pig Model.

Cross RW, Fenton KA, Geisbert JB, Ebihara H, Mire CE, Geisbert TW.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S258-70. doi: 10.1093/infdis/jiv182.

5.

Development and Characterization of a Guinea Pig-Adapted Sudan Virus.

Wong G, He S, Wei H, Kroeker A, Audet J, Leung A, Cutts T, Graham J, Kobasa D, Embury-Hyatt C, Kobinger GP, Qiu X.

J Virol. 2015 Oct 21;90(1):392-9. doi: 10.1128/JVI.02331-15.

6.

Lethality and pathogenesis of airborne infection with filoviruses in A129 α/β -/- interferon receptor-deficient mice.

Lever MS, Piercy TJ, Steward JA, Eastaugh L, Smither SJ, Taylor C, Salguero FJ, Phillpotts RJ.

J Med Microbiol. 2012 Jan;61(Pt 1):8-15. doi: 10.1099/jmm.0.036210-0.

PMID:
21852521
7.

Marburg virus infection in nonhuman primates: Therapeutic treatment by lipid-encapsulated siRNA.

Thi EP, Mire CE, Ursic-Bedoya R, Geisbert JB, Lee AC, Agans KN, Robbins M, Deer DJ, Fenton KA, MacLachlan I, Geisbert TW.

Sci Transl Med. 2014 Aug 20;6(250):250ra116. doi: 10.1126/scitranslmed.3009706.

8.

Immune Response to Marburg Virus Angola Infection in Nonhuman Primates.

Fernando L, Qiu X, Melito PL, Williams KJ, Feldmann F, Feldmann H, Jones SM, Alimonti JB.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S234-41. doi: 10.1093/infdis/jiv095.

PMID:
25957966
9.

Protection against lethal Marburg virus infection mediated by lipid encapsulated small interfering RNA.

Ursic-Bedoya R, Mire CE, Robbins M, Geisbert JB, Judge A, MacLachlan I, Geisbert TW.

J Infect Dis. 2014 Feb 15;209(4):562-70. doi: 10.1093/infdis/jit465.

10.

Key genomic changes necessary for an in vivo lethal mouse marburgvirus variant selection process.

Lofts LL, Wells JB, Bavari S, Warfield KL.

J Virol. 2011 Apr;85(8):3905-17. doi: 10.1128/JVI.02372-10.

11.

Macaque Monoclonal Antibodies Targeting Novel Conserved Epitopes within Filovirus Glycoprotein.

Keck ZY, Enterlein SG, Howell KA, Vu H, Shulenin S, Warfield KL, Froude JW, Araghi N, Douglas R, Biggins J, Lear-Rooney CM, Wirchnianski AS, Lau P, Wang Y, Herbert AS, Dye JM, Glass PJ, Holtsberg FW, Foung SK, Aman MJ.

J Virol. 2015 Oct 14;90(1):279-91. doi: 10.1128/JVI.02172-15.

12.

Postexposure antibody prophylaxis protects nonhuman primates from filovirus disease.

Dye JM, Herbert AS, Kuehne AI, Barth JF, Muhammad MA, Zak SE, Ortiz RA, Prugar LI, Pratt WD.

Proc Natl Acad Sci U S A. 2012 Mar 27;109(13):5034-9. doi: 10.1073/pnas.1200409109.

13.

Antiviral activity of a small-molecule inhibitor of filovirus infection.

Warren TK, Warfield KL, Wells J, Enterlein S, Smith M, Ruthel G, Yunus AS, Kinch MS, Goldblatt M, Aman MJ, Bavari S.

Antimicrob Agents Chemother. 2010 May;54(5):2152-9. doi: 10.1128/AAC.01315-09.

14.

Marburg virus Angola infection of rhesus macaques: pathogenesis and treatment with recombinant nematode anticoagulant protein c2.

Geisbert TW, Daddario-DiCaprio KM, Geisbert JB, Young HA, Formenty P, Fritz EA, Larsen T, Hensley LE.

J Infect Dis. 2007 Nov 15;196 Suppl 2:S372-81.

PMID:
17940973
15.

Codon-optimized filovirus DNA vaccines delivered by intramuscular electroporation protect cynomolgus macaques from lethal Ebola and Marburg virus challenges.

Grant-Klein RJ, Altamura LA, Badger CV, Bounds CE, Van Deusen NM, Kwilas SA, Vu HA, Warfield KL, Hooper JW, Hannaman D, Dupuy LC, Schmaljohn CS.

Hum Vaccin Immunother. 2015;11(8):1991-2004. doi: 10.1080/21645515.2015.1039757.

16.

Inhibition of Ebola and Marburg Virus Entry by G Protein-Coupled Receptor Antagonists.

Cheng H, Lear-Rooney CM, Johansen L, Varhegyi E, Chen ZW, Olinger GG, Rong L.

J Virol. 2015 Oct;89(19):9932-8. doi: 10.1128/JVI.01337-15.

17.

Discovery of common marburgvirus protective epitopes in a BALB/c mouse model.

Kalina WV, Warfield KL, Olinger GG, Bavari S.

Virol J. 2009 Aug 27;6:132. doi: 10.1186/1743-422X-6-132.

18.

Role of EXT1 and Glycosaminoglycans in the Early Stage of Filovirus Entry.

O'Hearn A, Wang M, Cheng H, Lear-Rooney CM, Koning K, Rumschlag-Booms E, Varhegyi E, Olinger G, Rong L.

J Virol. 2015 May;89(10):5441-9. doi: 10.1128/JVI.03689-14.

19.

Development of a murine model for aerosolized ebolavirus infection using a panel of recombinant inbred mice.

Zumbrun EE, Abdeltawab NF, Bloomfield HA, Chance TB, Nichols DK, Harrison PE, Kotb M, Nalca A.

Viruses. 2012 Dec 3;4(12):3468-93. doi: 10.3390/v4123468. Review.

20.

Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.

Jones SM, Feldmann H, Ströher U, Geisbert JB, Fernando L, Grolla A, Klenk HD, Sullivan NJ, Volchkov VE, Fritz EA, Daddario KM, Hensley LE, Jahrling PB, Geisbert TW.

Nat Med. 2005 Jul;11(7):786-90.

PMID:
15937495
Items per page

Supplemental Content

Support Center